Novartis' Hemophilia Drug Patent Suit Stays In Texas

By Abigail Rubenstein

Law360, New York (September 01, 2010, 5:53 PM ET) -- A federal judge in the Eastern District of Texas won't reconsider Wyeth Inc.'s bid to move Novartis AG's lawsuit accusing it of infringing patents for hemophilia treatments.

Judge T. John Ward of the U.S. District Court for the Eastern District of Texas on Monday denied Wyeth's motion to reconsider a magistrate judge's decision to reject its bid to transfer the patent infringement case to the Northern District of California.

Judge Ward held that magistrate Judge Charles Everingham's March 31 decision denying Wyeth's transfer motion and calling...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles